Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Novel assessment tools to evaluate clinical and laboratory responses in a subset of patients enrolled in the Rituximab in Myositis trial.

Rider LG, Yip AL, Horkayne-Szakaly I, Volochayev R, Shrader JA, Turner ML, Kong HH, Jain MS, Jansen AV, Oddis CV, Fleisher TA, Miller FW.

Clin Exp Rheumatol. 2014 Jul 28. [Epub ahead of print]

PMID:
25068290
[PubMed - as supplied by publisher]
2.

A58: demographics, clinical features and therapies of patients with juvenile dermatomyositis participating in a national myositis patient registry.

Rider LG, Faiq A, Farhadi PN, Bayat N, Itert L, Chase M, Ulrey R, Malley K, Wilkerson J, Johnson A, Rose K, Morris R, Parks C, Giannini EH, Brunner H, Goldberg B, Miller FW.

Arthritis Rheumatol. 2014 Mar;66 Suppl 11:S86-7. doi: 10.1002/art.38474.

PMID:
24677989
[PubMed - in process]
3.

A47: progress report on the development of new classification criteria for adult and juvenile idiopathic inflammatory myopathies.

Pilkington C, Tjärnlund A, Bottai M, Rider LG, Werth VP, Visser Md, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Miller FW, Lundberg IE; members of the IMCCP International Myositis Classification Criteria Project.

Arthritis Rheumatol. 2014 Mar;66 Suppl 11:S70-1. doi: 10.1002/art.38463.

PMID:
24677977
[PubMed - in process]
4.

A25: the association of immunogenetic and environmental factors with disease course in patients with juvenile idiopathic inflammatory myopathies.

Habers GE, Huber AM, Mamyrova G, O'Hanlon TP, Adams S, Pandey JP, Miller FW, Boonacker C, van Royen-Kerkhof A, Rider LG.

Arthritis Rheumatol. 2014 Mar;66 Suppl 11:S39-40. doi: 10.1002/art.38441.

PMID:
24677952
[PubMed - in process]
5.

Twins discordant for myositis and systemic lupus erythematosus show markedly enriched autoantibodies in the affected twin supporting environmental influences in pathogenesis.

Gan L, O'Hanlon TP, Gordon AS, Rider LG, Miller FW, Burbelo PD.

BMC Musculoskelet Disord. 2014 Mar 6;15:67. doi: 10.1186/1471-2474-15-67.

PMID:
24602337
[PubMed - in process]
Free PMC Article
6.

Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.

Aggarwal R, Bandos A, Reed AM, Ascherman DP, Barohn RJ, Feldman BM, Miller FW, Rider LG, Harris-Love MO, Levesque MC; RIM Study Group, Oddis CV.

Arthritis Rheumatol. 2014 Mar;66(3):740-9. doi: 10.1002/art.38270.

PMID:
24574235
[PubMed - indexed for MEDLINE]
7.

Confusion concerning multiple versions of the childhood myositis assessment scale.

Huber AM, Lovell DJ, Pilkington CA, Rennebohm RM, Rider LG.

Arthritis Care Res (Hoboken). 2014 Apr;66(4):648. doi: 10.1002/acr.22239. No abstract available.

PMID:
24285368
[PubMed - indexed for MEDLINE]
8.

Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies.

Rider LG, Katz JD, Jones OY.

Rheum Dis Clin North Am. 2013 Nov;39(4):877-904. doi: 10.1016/j.rdc.2013.06.001. Epub 2013 Sep 19. Review.

PMID:
24182859
[PubMed - indexed for MEDLINE]
9.

Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies.

Huber AM, Mamyrova G, Lachenbruch PA, Lee JA, Katz JD, Targoff IN, Miller FW, Rider LG; Childhood Myositis Heterogeneity Collaborative Study Group.

Arthritis Care Res (Hoboken). 2014 May;66(5):732-40. doi: 10.1002/acr.22212.

PMID:
24151254
[PubMed - indexed for MEDLINE]
10.

Post-zygotic and inter-individual structural genetic variation in a presumptive enhancer element of the locus between the IL10Rβ and IFNAR1 genes.

Razzaghian HR, Forsberg LA, Prakash KR, Przerada S, Paprocka H, Zywicka A, Westerman MP, Pedersen NL, O'Hanlon TP, Rider LG, Miller FW, Srutek E, Jankowski M, Zegarski W, Piotrowski A, Absher D, Dumanski JP.

PLoS One. 2013 Sep 4;8(9):e67752. doi: 10.1371/journal.pone.0067752. eCollection 2013.

PMID:
24023707
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders.

Miller FW, Cooper RG, Vencovský J, Rider LG, Danko K, Wedderburn LR, Lundberg IE, Pachman LM, Reed AM, Ytterberg SR, Padyukov L, Selva-O'Callaghan A, Radstake TR, Isenberg DA, Chinoy H, Ollier WE, O'Hanlon TP, Peng B, Lee A, Lamb JA, Chen W, Amos CI, Gregersen PK; Myositis Genetics Consortium.

Arthritis Rheum. 2013 Dec;65(12):3239-47. doi: 10.1002/art.38137.

PMID:
23983088
[PubMed - indexed for MEDLINE]
12.

Clinical and laboratory features distinguishing juvenile polymyositis and muscular dystrophy.

Mamyrova G, Katz JD, Jones RV, Targoff IN, Lachenbruch PA, Jones OY, Miller FW, Rider LG; Childhood Myositis Heterogeneity Collaborative Study Group.

Arthritis Care Res (Hoboken). 2013 Dec;65(12):1969-75. doi: 10.1002/acr.22088.

PMID:
23925923
[PubMed - indexed for MEDLINE]
13.

The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.

Rider LG, Shah M, Mamyrova G, Huber AM, Rice MM, Targoff IN, Miller FW; Childhood Myositis Heterogeneity Collaborative Study Group.

Medicine (Baltimore). 2013 Jul;92(4):223-43. doi: 10.1097/MD.0b013e31829d08f9.

PMID:
23877355
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis.

Shah M, Targoff IN, Rice MM, Miller FW, Rider LG; Childhood Myositis Heterogeneity Collaborative Study Group.

Arthritis Rheum. 2013 Jul;65(7):1934-41. doi: 10.1002/art.37985.

PMID:
23658122
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.

Shah M, Mamyrova G, Targoff IN, Huber AM, Malley JD, Rice MM, Miller FW, Rider LG; Childhood Myositis Heterogeneity Collaborative Study Group.

Medicine (Baltimore). 2013 Jan;92(1):25-41. doi: 10.1097/MD.0b013e31827f264d.

PMID:
23263716
[PubMed - indexed for MEDLINE]
16.

Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial.

Oddis CV, Reed AM, Aggarwal R, Rider LG, Ascherman DP, Levesque MC, Barohn RJ, Feldman BM, Harris-Love MO, Koontz DC, Fertig N, Kelley SS, Pryber SL, Miller FW, Rockette HE; RIM Study Group.

Arthritis Rheum. 2013 Feb;65(2):314-24. doi: 10.1002/art.37754.

PMID:
23124935
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis.

Lazarevic D, Pistorio A, Palmisani E, Miettunen P, Ravelli A, Pilkington C, Wulffraat NM, Malattia C, Garay SM, Hofer M, Quartier P, Dolezalova P, Penades IC, Ferriani VP, Ganser G, Kasapcopur O, Melo-Gomes JA, Reed AM, Wierzbowska M, Rider LG, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Ann Rheum Dis. 2013 May;72(5):686-93. doi: 10.1136/annrheumdis-2012-201483. Epub 2012 Jun 26.

PMID:
22736096
[PubMed - indexed for MEDLINE]
18.

Laboratory Test Abnormalities are Common in Polymyositis and Dermatomyositis and Differ Among Clinical and Demographic Groups.

Volochayev R, Csako G, Wesley R, Rider LG, Miller FW.

Open Rheumatol J. 2012;6:54-63. doi: 10.2174/1874312901206010054. Epub 2012 Jun 1.

PMID:
22723809
[PubMed]
Free PMC Article
20.

Childhood socioeconomic factors and perinatal characteristics influence development of rheumatoid arthritis in adulthood.

Parks CG, D'Aloisio AA, DeRoo LA, Huiber K, Rider LG, Miller FW, Sandler DP.

Ann Rheum Dis. 2013 Mar;72(3):350-6. doi: 10.1136/annrheumdis-2011-201083. Epub 2012 May 14. Erratum in: Ann Rheum Dis. 2013 May;72(5):788.

PMID:
22586176
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk